(5Z,13E)-(15S)-9α,11α,15-trihydroxyprosta-5,13-dienoate:NADP+ 9-oxidoreductase inhibitor
|
ChEBI
|
(5Z,13E)-(15S)-9α,11α,15-trihydroxyprosta-5,13-dienoate:NADP+ 9-oxidoreductase inhibitors
|
ChEBI
|
9-keto-prostaglandin E2 reductase inhibitor
|
ChEBI
|
9-keto-prostaglandin E2 reductase inhibitors
|
ChEBI
|
9-ketoprostaglandin reductase inhibitor
|
ChEBI
|
9-ketoprostaglandin reductase inhibitors
|
ChEBI
|
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitors
|
ChEBI
|
EC 1.1.1.189 inhibitor
|
ChEBI
|
EC 1.1.1.189 inhibitors
|
ChEBI
|
PGE-9-ketoreductase inhibitor
|
ChEBI
|
PGE-9-ketoreductase inhibitors
|
ChEBI
|
PGE2 9-oxoreductase inhibitor
|
ChEBI
|
PGE2 9-oxoreductase inhibitors
|
ChEBI
|
PGE2-9-ketoreductase inhibitor
|
ChEBI
|
PGE2-9-ketoreductase inhibitors
|
ChEBI
|
PGE2-9-OR inhibitor
|
ChEBI
|
PGE2-9-OR inhibitors
|
ChEBI
|
prostaglandin 9-ketoreductase inhibitor
|
ChEBI
|
prostaglandin 9-ketoreductase inhibitors
|
ChEBI
|
prostaglandin E 9-ketoreductase inhibitor
|
ChEBI
|
prostaglandin E 9-ketoreductase inhibitors
|
ChEBI
|
prostaglandin E2-9-oxoreductase inhibitor
|
ChEBI
|
prostaglandin E2-9-oxoreductase inhibitors
|
ChEBI
|
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitor
|
ChEBI
|
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitors
|
ChEBI
|
reductase, 15-hydroxy-9-oxoprostaglandin inhibitor
|
ChEBI
|
reductase, 15-hydroxy-9-oxoprostaglandin inhibitors
|
ChEBI
|